Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglin
- 1 March 2000
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 36 (5), 675-681
- https://doi.org/10.1016/s0959-8049(99)00335-4
Abstract
No abstract availableKeywords
Funding Information
- Société Française de Radiologie
- National Institutes of Health (2-RO1 CA 59649-05)
This publication has 27 references indexed in Scilit:
- Defective Angiogenesis in Mice Lacking EndoglinScience, 1999
- Expression of Endoglin mRNA and Protein in Human Vascular Smooth Muscle CellsBiochemical and Biophysical Research Communications, 1998
- Antibody-Mediated versus Nontargeted Delivery in a Human Small Cell Lung Carcinoma ModelBioconjugate Chemistry, 1998
- Targeting the vasculature of solid tumoursJournal of Controlled Release, 1997
- Endoglin modulates cellular responses to TGF-beta 1.The Journal of cell biology, 1996
- Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1Nature Genetics, 1994
- Role of angiogenesis in patients with cerebral ischemic stroke.Stroke, 1994
- Breast Carcinoma: Comparative Study of Tummor Vasculature Using Two Endothelial Cell MarkersJNCI Journal of the National Cancer Institute, 1994
- Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-β ligandGene, 1994
- A New 180-kDa Dermal Endothelial Cell Activation Antigen: In Vitro and In Situ CharacteristicsJournal of Investigative Dermatology, 1993